Lang Xia-Bing, Yang Yi, Yang Ju-Rong, Wan Jian-Xin, Yu Sheng-Qiang, Cui Jiong, Tang Xiao-Jing, Chen Jianghua
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zheijang, China.
Department of Nephrology, Daping Hospital, Third Military Medical University, Chongqing, China.
Kidney Blood Press Res. 2018;43(1):125-133. doi: 10.1159/000487366. Epub 2018 Feb 8.
BACKGROUND/AIMS: A lack of baseline serum creatinine (SCr) data leads to underestimation of the burden caused by acute kidney injury (AKI) in developing countries. The goal of this study was to investigate the effects of various baseline SCr analysis methods on the current diagnosis of AKI in hospitalized patients.
Patients with at least one SCr value during their hospital stay between January 1, 2011 and December 31, 2012 were retrospectively included in the study. The baseline SCr was determined either by the minimum SCr (SCrMIN) or the estimated SCr using the MDRD formula (SCrGFR-75). We also used the dynamic baseline SCr (SCrdynamic) in accordance with the 7 day/48 hour time window. AKI was defined based on the KDIGO SCr criteria.
Of 562,733 hospitalized patients, 350,458 (62.3%) had at least one SCr determination, and 146,185 (26.0%) had repeat SCr tests. AKI was diagnosed in 13,883 (2.5%) patients using the SCrMIN, 21,281 (3.8%) using the SCrGFR-75 and 9,288 (1.7%) using the SCrdynamic. Compared with the non-AKI patients, AKI patients had a higher in-hospital mortality rate regardless of the baseline SCr analysis method.
Because of the scarcity of SCr data, imputation of the baseline SCr is necessary to remedy the missing data. The detection rate of AKI varies depending on the different imputation methods. SCrGFR-75 can identify more AKI cases than the other two methods.
背景/目的:在发展中国家,由于缺乏基线血清肌酐(SCr)数据,导致对急性肾损伤(AKI)造成的负担估计不足。本研究的目的是调查各种基线SCr分析方法对住院患者当前AKI诊断的影响。
回顾性纳入2011年1月1日至2012年12月31日住院期间至少有一次SCr值的患者。基线SCr通过最低SCr(SCrMIN)或使用MDRD公式估算的SCr(SCrGFR-75)来确定。我们还根据7天/48小时时间窗使用动态基线SCr(SCrdynamic)。根据KDIGO SCr标准定义AKI。
在562,733例住院患者中,350,458例(62.3%)至少有一次SCr测定,146,185例(26.0%)进行了重复SCr检测。使用SCrMIN诊断出13,883例(2.5%)AKI患者,使用SCrGFR-75诊断出21,281例(3.8%),使用SCrdynamic诊断出9,288例(1.7%)。无论采用何种基线SCr分析方法,与非AKI患者相比,AKI患者的院内死亡率更高。
由于SCr数据稀缺,有必要对基线SCr进行估算以弥补缺失数据。AKI的检出率因不同的估算方法而异。与其他两种方法相比,SCrGFR-75能识别出更多的AKI病例。